Brain, Vol. 126, No. 1, 176-185,
January 2003
© 2003 Guarantors of Brain
doi: 10.1093/brain/awg017
The non-classical MHC molecule HLA-G protects human muscle cells from immune-mediated lysis: implications for myoblast transplantation and gene therapy
1 Department of Neurology, University of Tübingen, Medical School, Tübingen, 2 Department of Anthropology and Human Genetics, 3 Genzentrum and Friedrich-Baur Institut and Department of Neurology and 4 Institute for Clinical Neuroimmunology, Ludwig Maximilians University, Munich, Germany
Correspondence to: Dr Heinz Wiendl, Department of Neurology, University of Tübingen, Hoppe-Seyler-Strasse 3, D-72076 Tübingen, Germany E-mail: heinz.wiendl{at}uni-tuebingen.de*These two authors contributed equally to this work
HLA-G is a non-classical MHC class I molecule with highly limited tissue distribution which has been attributed chiefly immune-regulatory functions. We previously have reported that HLA-G is expressed in inflamed muscle in vivo and by cultured myoblasts in vitro. Here, we used the in vitro models of human myoblasts or TE671 muscle rhabdomyosarcoma cells to characterize the functional role of HLA-G for muscle immune cell interactions. Gene transfer of the two major isoforms of HLA-G (transmembranous HLA-G1 and soluble HLA-G5) into TE671 rendered these cells resistant to alloreactive lysis by direct inhibition of natural killer (NK) cells, and CD4 and CD8 T cells. Further, HLA-G reduced alloproliferation, interfered with effective priming of antigen-specific cytotoxic T cells and reduced antigen-specific alloreactive lysis. HLA-G pre-induced on cultured myoblasts inhibited lysis by alloreactive peripheral blood mononuclear cells. This protection was reversed by a neutralizing HLA-G antibody. Interestingly, a few HLA-G-positive cells within a population of HLA-G-negative muscle target cells conveyed significant inhibitory effects on alloreactive lysis. Our results reveal further insights into the immunobiology of muscle and suggest that ectopic expression of HLA-G may promote the survival of transplanted myoblasts in the future treatment of hereditary muscle diseases. Further, HLA-G could represent a novel self-derived anti-inflammatory principle applicable in strategies against inflammatory aggression.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y.-H. Huang, A. L. Zozulya, C. Weidenfeller, N. Schwab, and H. Wiendl T cell suppression by naturally occurring HLA-G-expressing regulatory CD4+ T cells is IL-10-dependent and reversible J. Leukoc. Biol., August 1, 2009; 86(2): 273 - 281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Feger, E. Tolosa, Y.-H. Huang, A. Waschbisch, T. Biedermann, A. Melms, and H. Wiendl HLA-G expression defines a novel regulatory T-cell subset present in human peripheral blood and sites of inflammation Blood, July 15, 2007; 110(2): 568 - 577. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. LeMaoult, J. Caumartin, M. Daouya, B. Favier, S. L. Rond, A. Gonzalez, and E. D. Carosella Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells Blood, March 1, 2007; 109(5): 2040 - 2048. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B.F. Barrier, B.S. Kendall, C.E. Ryan, and K.L. Sharpe-Timms HLA-G is expressed by the glandular epithelium of peritoneal endometriosis but not in eutopic endometrium Hum. Reprod., April 1, 2006; 21(4): 864 - 869. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Lafon, C. Prehaud, F. Megret, M. Lafage, G. Mouillot, M. Roa, P. Moreau, N. Rouas-Freiss, and E. D. Carosella Modulation of HLA-G Expression in Human Neural Cells after Neurotropic Viral Infections J. Virol., December 15, 2005; 79(24): 15226 - 15237. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Wiendl, U. Feger, M. Mittelbronn, C. Jack, B. Schreiner, C. Stadelmann, J. Antel, W. Brueck, R. Meyermann, A. Bar-Or, et al. Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity Brain, November 1, 2005; 128(11): 2689 - 2704. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Gonzalez-Hernandez, J. LeMaoult, A. Lopez, E. Alegre, J. Caumartin, S. L. Rond, M. Daouya, P. Moreau, and E. D. Carosella Linking Two Immuno-Suppressive Molecules: Indoleamine 2,3 Dioxygenase Can Modify HLA-G Cell-Surface Expression Biol Reprod, September 1, 2005; 73(3): 571 - 578. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Le Friec, F. Gros, Y. Sebti, V. Guilloux, C. Pangault, R. Fauchet, and L. Amiot Capacity of myeloid and plasmacytoid dendritic cells especially at mature stage to express and secrete HLA-G molecules J. Leukoc. Biol., December 1, 2004; 76(6): 1125 - 1133. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. H. McIntire, P. J. Morales, M. G. Petroff, M. Colonna, and J. S. Hunt Recombinant HLA-G5 and -G6 drive U937 myelomonocytic cell production of TGF-{beta}1 J. Leukoc. Biol., December 1, 2004; 76(6): 1220 - 1228. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. LeMaoult, I. Krawice-Radanne, J. Dausset, and E. D. Carosella HLA-G1-expressing antigen-presenting cells induce immunosuppressive CD4+ T cells PNAS, May 4, 2004; 101(18): 7064 - 7069. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. J. Morales, J. L. Pace, J. S. Platt, T. A. Phillips, K. Morgan, A. T. Fazleabas, and J. S. Hunt Placental Cell Expression of HLA-G2 Isoforms Is Limited to the Invasive Trophoblast Phenotype J. Immunol., December 1, 2003; 171(11): 6215 - 6224. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Wiendl, M. Mitsdoerffer, D. Schneider, A. Melms, H. Lochmuller, R. Hohlfeld, and M. Weller Muscle fibres and cultured muscle cells express the B7.1/2-related inducible co-stimulatory molecule, ICOSL: implications for the pathogenesis of inflammatory myopathies Brain, May 1, 2003; 126(5): 1026 - 1035. [Abstract] [Full Text] [PDF]
|
|